Stay updated on Pembrolizumab Combo in Triple Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Triple Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Triple Negative Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    New UI/help sections and a version update were added: Last verified, Last known status was, How to Read a Study Record, Common Questions, How to Join a Study, and an Intervention/Treatment heading. Older items Verified, Last known status was:, Intervention / Treatment, and Revision: v3.5.5 were removed.
    Difference
    1%
    Check dated 2026-06-13T00:31:48.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A new page revision (v3.5.5) was added and the previous revision (v3.5.4) was removed. This reflects an update to the page or its template rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-06-05T16:41:50.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    A new revision tag, v3.5.4, was added and the previous tag, v3.5.3, removed, indicating a deployment-level update to the page's version. This reflects an update to the site's backend/content management rather than changes to trial details.
    Difference
    0.0%
    Check dated 2026-05-15T06:12:03.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Update to the study record's status metadata, including the verifier (University of Kansas Medical Center) and the verification date (2024-04). This reflects administrative tracking rather than changes to core study content.
    Difference
    0.4%
    Check dated 2026-05-01T08:20:36.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The page’s software/UI revision indicator was updated from v3.5.2 to v3.5.3, reflecting a backend or display version change rather than a modification to the clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-24T05:55:00.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added. Revision: v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-17T02:35:54.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Triple Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Triple Negative Breast Cancer Clinical Trial page.